YIA
REGN icon

YHB Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

YHB Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$431K Hold
568
– – 0.03% 232
2026
Q2 		$354K Hold
568
– – 0.02% 251
2026
Q1 		$439K Hold
568
– – 0.03% 222
2025
Q4 		$438K Sell
568
-5
-0.9% -$3.4K 0.03% 222
2025
Q3 		$322K Sell
573
-2
-0.3% -$1.13K 0.02% 251
2025
Q2 		$302K Hold
575
– – 0.02% 254
2025
Q1 		$365K Sell
575
-2
-0.3% -$1.38K 0.03% 225
2024
Q4 		$411K Hold
577
– – 0.03% 210
2024
Q3 		$607K Hold
577
– – 0.05% 189
2024
Q2 		$606K Hold
577
– – 0.05% 183
2024
Q1 		$555K Sell
577
-56
-9% -$53.2K 0.05% 186
2023
Q4 		$556K Sell
633
-12
-2% -$9.88K 0.05% 181
2023
Q3 		$531K Sell
645
-25
-4% -$19.6K 0.05% 185
2023
Q2 		$481K Sell
670
-37
-5% -$28.5K 0.04% 193
2023
Q1 		$581K Sell
707
-72
-9% -$54.3K 0.06% 178
2022
Q4 		$562K Sell
779
-14
-2% -$10.3K 0.06% 173
2022
Q3 		$546K Hold
793
– – 0.06% 182
2022
Q2 		$469K Sell
793
-10
-1% -$6.5K 0.05% 190
2022
Q1 		$561K Hold
803
– – 0.05% 190
2021
Q4 		$507K Hold
803
– – 0.04% 210
2021
Q3 		$486K Hold
803
– – 0.04% 202
2021
Q2 		$449K Hold
803
– – 0.04% 206
2021
Q1 		$404K Sell
803
-10
-1% -$4.87K 0.04% 213
2020
Q4 		$393K Buy
813
+3
+0.4% +$1.62K 0.04% 208
2020
Q3 		$453K Sell
810
-100
-11% -$60.6K 0.05% 195
2020
Q2 		$568K Hold
910
– – 0.08% 127
2020
Q1 		$444K Buy
910
+10
+1% +$4.13K 0.08% 125
2019
Q4 		$338K Sell
900
-800
-47% -$269K 0.05% 147
2019
Q3 		$472K Buy
+1,700
New +$503K 0.07% 134

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

YHB Investment Advisors's REGN Position: Q3 2026 in Review

YHB Investment Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 568 shares worth $431K. The position accounts for 0.03% of the portfolio, ranked #232.

YHB Investment Advisors first reported a position in REGN in Q3 2019 and has held it in 29 quarters since. The position peaked at $607K in Q3 2024. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • YHB Investment Advisors held 568 shares of Regeneron Pharmaceuticals worth $431K as of Q3 2026.
  • YHB Investment Advisors left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.03% of YHB Investment Advisors's portfolio in Q3 2026, its #232 holding.
  • YHB Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 29 quarters since.
  • YHB Investment Advisors's Regeneron Pharmaceuticals position peaked at $607K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on YHB Investment Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.